Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...
Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions ...
Investor's Business Daily on MSN
Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue
Sanofi stock jumped early Friday on better-than-expected third-quarter sales and earnings, and a strong showing from Dupixent ...
Everyday Health on MSN
Chronic Idiopathic Urticaria Treatment: Medication, Lifestyle Changes, and More
Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...
Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Learn smart ways to save + get daily chances to win gift cards ...
Women’s marathon world record holder Ruth Chepngetich has been banned for three years for a violation of anti-doping rules. The Athletics Integrity Unit (AIU) confirmed the ban in a statement on ...
Last year, a group of researchers won the 2024 Ig Nobel Prize in Physiology for discovering that many mammals are capable of breathing through their anus. But as with many Ig Nobel awards, there is a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with overweight and type 1 diabetes using ...
An oral GLP-1 receptor agonist, Rybelsus will be available in 7-mg and 14-mg doses. "As the only FDA-approved GLP-1 therapy in a pill, now recognized for its proven cardiovascular benefits, a new ...
Roche’s giredestrant was shown to reduce the risk of breast cancer progression or death by 62% for a specific cohort of a phase 3 trial, as the pharma plans for the oral selective estrogen receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results